55I LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$7.16M Buy
43,816
+24,999
+133% +$4.23M 0.2% 76
2022
Q2
$3.34M Buy
18,817
+627
+3% +$112K 0.09% 129
2022
Q1
$3.22M Buy
18,190
+1,222
+7% +$208K 0.08% 155
2021
Q4
$2.9M Buy
16,968
+332
+2% +$54.4K 0.07% 152
2021
Q3
$2.69M Buy
16,636
+3,926
+31% +$670K 0.08% 148
2021
Q2
$2.09M Buy
12,710
+3,560
+39% +$589K 0.07% 137
2021
Q1
$1.5M Buy
9,150
+1,266
+16% +$205K 0.08% 138
2020
Q4
$1.24M Buy
7,884
+1,203
+18% +$178K 0.09% 110
2020
Q3
$995K Buy
6,681
+3,124
+88% +$462K 0.09% 130
2020
Q2
$500K Buy
3,557
+1,801
+103% +$262K 0.08% 144
2020
Q1
$248K Buy
+1,756
New +$249K 0.07% 144

Other funds holding JNJ

55I LLC's JNJ Position: Q3 2022 in Review

55I LLC increased its Johnson & Johnson (JNJ) stake by 133% in Q3 2022, buying an estimated $4.23M and bringing the position to 43,816 shares worth $7.16M. The position accounts for 0.2% of the portfolio, ranked #76.

55I LLC first reported a position in JNJ in Q1 2020 and has held it in 11 quarters since. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • 55I LLC held 43,816 shares of Johnson & Johnson worth $7.16M as of Q3 2022.
  • 55I LLC bought 24,999 Johnson & Johnson shares in Q3 2022, an estimated $4.23M.
  • Johnson & Johnson made up 0.2% of 55I LLC's portfolio in Q3 2022, its #76 holding.
  • 55I LLC first reported a position in Johnson & Johnson in Q1 2020 and has held it in 11 quarters since.
  • 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.